CRLFCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。CRLF遺伝子サイレンサーは、CRLF CRISPR/Cas9ノックアウトプラスミドとCRLFDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のCRLFCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
CRLF CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CRLF1 CRISPR/Cas9 KOプラスミド (h) | sc-405550 | h | Gene Knockout | GFP | 0 | ||
CRLF1 HDRプラスミド (h) | sc-405550-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRLF1 Double Nickaseプラスミド (h) | sc-405550-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRLF1 Double Nickaseプラスミド (h2) | sc-405550-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRLF1 CRISPR/Cas9 KOプラスミド (m) | sc-419808 | m | Gene Knockout | GFP | 0 | ||
CRLF1 HDRプラスミド (m) | sc-419808-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CRLF1 Double Nickaseプラスミド (m) | sc-419808-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRLF1 Double Nickaseプラスミド (m2) | sc-419808-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CRLF3 CRISPR/Cas9 KOプラスミド (h) | sc-407538 | h | Gene Knockout | GFP | 0 | ||
CRLF3 HDRプラスミド (h) | sc-407538-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRLF3 Double Nickaseプラスミド (h) | sc-407538-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRLF3 Double Nickaseプラスミド (h2) | sc-407538-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CRLF3 CRISPR/Cas9 KOプラスミド (m) | sc-424857 | m | Gene Knockout | GFP | 0 | ||
CRLF3 HDRプラスミド (m) | sc-424857-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CRLF3 Double Nickaseプラスミド (m) | sc-424857-NIC | m | Gene Knockout | Puromycin | 0 | ||
CRLF3 Double Nickaseプラスミド (m2) | sc-424857-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CRLF CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
CRLF1 CRISPR Activationプラスミド (h) | sc-405550-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activationプラスミド (h2) | sc-405550-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (h) | sc-405550-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (h2) | sc-405550-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activationプラスミド (m) | sc-419808-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 CRISPR Activationプラスミド (m2) | sc-419808-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (m) | sc-419808-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF1 Lentiviral Activation Particles (m2) | sc-419808-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activationプラスミド (h) | sc-407538-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activationプラスミド (h2) | sc-407538-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (h) | sc-407538-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (h2) | sc-407538-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activationプラスミド (m) | sc-424857-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 CRISPR Activationプラスミド (m2) | sc-424857-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (m) | sc-424857-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRLF3 Lentiviral Activation Particles (m2) | sc-424857-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |